Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the basic domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /srv/www/wordpress/wp-includes/functions.php on line 6114
CagriSema confers 15.7% weight loss at 68 weeks for adults with obesity, type 2 diabetes – Medi-News.in

CagriSema confers 15.7% weight loss at 68 weeks for adults with obesity, type 2 diabetes

Adults with obesity and type 2 diabetes receiving once-weekly combination cagrilintide 2.4 mg and semaglutide 2.4 mg lost 15.7% of their body weight at 68 weeks, according to topline data from the REDEFINE 2 trial.As Healio previously reported in December, CagriSema (Novo Nordisk) conferred a 22.7% weight loss at 68 weeks among adults with obesity and without diabetes in the REDEFINE 1 trial. In the REDEFINE 2 trial, 1,206 adults with obesity or overweight plus type 2 diabetes were randomly assigned to once-weekly CagriSema or placebo for 68 weeks.In the trial product estimand, adultsRead More

Leave a Reply

Your email address will not be published. Required fields are marked *

➤